HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Debra L Laskin Selected Research

Mechlorethamine (Nitrogen Mustard)

1/2021Macrophage activation in the lung during the progression of nitrogen mustard induced injury is associated with histone modifications and altered miRNA expression.
11/2020Transcriptional profiling of lung macrophages during pulmonary injury induced by nitrogen mustard.
11/2020Assessment of mustard vesicant lung injury and anti-TNF-α efficacy in rodents using live-animal imaging.
1/2020Antioxidant/stress response in mouse epidermis following exposure to nitrogen mustard.
1/2020Lung injury, oxidative stress and fibrosis in mice following exposure to nitrogen mustard.
12/2019Regulation of Macrophage Foam Cell Formation During Nitrogen Mustard (NM)-Induced Pulmonary Fibrosis by Lung Lipids.
11/2018Protective Role of Surfactant Protein-D Against Lung Injury and Oxidative Stress Induced by Nitrogen Mustard.
1/2017Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor.
3/2016Characterization of Distinct Macrophage Subpopulations during Nitrogen Mustard-Induced Lung Injury and Fibrosis.
1/2016Mustard vesicants alter expression of the endocannabinoid system in mouse skin.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Debra L Laskin Research Topics

Disease

44Inflammation (Inflammations)
10/2021 - 04/2002
35Lung Injury
10/2021 - 04/2002
13Edema (Dropsy)
10/2021 - 12/2010
13Fibrosis (Cirrhosis)
01/2021 - 12/2012
11Necrosis
07/2012 - 04/2002
9Endotoxemia
02/2013 - 01/2002
7Acute Lung Injury
10/2021 - 08/2014
7Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 03/2007
7Wounds and Injuries (Trauma)
01/2019 - 07/2012
7Pneumonia (Pneumonitis)
01/2017 - 04/2002
6Poisoning
02/2020 - 02/2011
6Hyperplasia
11/2018 - 04/2002
5Neoplasms (Cancer)
01/2021 - 03/2008
4Lung Diseases (Lung Disease)
12/2017 - 05/2002
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2020 - 02/2011
3Asthma (Bronchial Asthma)
01/2019 - 08/2010
3Infections
01/2018 - 01/2004
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2020 - 01/2019
2Chronic Obstructive Pulmonary Disease (COPD)
01/2019 - 12/2017
2Bronchiolitis
06/2013 - 01/2011
1Corneal Injuries
10/2022
1Dyslipidemias (Dyslipidemia)
10/2020
1Hyperoxia
01/2020
1Chronic Disease (Chronic Diseases)
01/2019
1Hypertrophy
11/2018
1Bronchiectasis
11/2018
1Sarcoidosis (Schaumann Disease)
12/2017
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2017

Drug/Important Bio-Agent (IBA)

20Irritants (Vesicants)IBA
11/2020 - 06/2010
16OzoneIBA
10/2020 - 04/2002
15Mustard Gas (Sulfur Mustard)IBA
10/2022 - 06/2010
15Mechlorethamine (Nitrogen Mustard)FDA Link
01/2021 - 01/2011
11Acetaminophen (Paracetamol)FDA LinkGeneric
07/2012 - 05/2002
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 10/2002
9Alkylating AgentsIBA
01/2021 - 10/2011
9Proteins (Proteins, Gene)FDA Link
03/2015 - 04/2002
6Transaminases (Aminotransferases)IBA
07/2012 - 11/2003
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2015 - 04/2002
5Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2012 - 04/2002
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2011 - 04/2002
4Reactive Nitrogen SpeciesIBA
01/2019 - 08/2010
4NitrogenIBA
01/2016 - 05/2002
3Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2021 - 10/2011
3CytokinesIBA
01/2021 - 01/2016
3DNA (Deoxyribonucleic Acid)IBA
06/2020 - 10/2007
3Connective Tissue Growth FactorIBA
01/2019 - 01/2011
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 03/2004
3Peptide Hydrolases (Proteases)FDA Link
01/2019 - 05/2002
3Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2018 - 10/2013
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2016 - 10/2010
3Oxygen (Dioxygen)IBA
01/2016 - 05/2002
3Galectin 3 (LGALS3)IBA
04/2015 - 09/2012
3Surface-Active Agents (Surfactants)IBA
08/2014 - 09/2012
32-chloroethyl ethyl sulfideIBA
05/2012 - 12/2010
3EicosanoidsIBA
06/2010 - 04/2002
3LipopolysaccharidesIBA
10/2007 - 01/2002
3NF-kappa B (NF-kB)IBA
10/2007 - 03/2002
2Messenger RNA (mRNA)IBA
01/2021 - 08/2010
2CollagenIBA
12/2020 - 02/2005
2ChlorineIBA
11/2020 - 07/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2020 - 05/2002
2ChemokinesIBA
11/2020 - 03/2016
2LigandsIBA
10/2020 - 10/2002
2DNA-Activated Protein KinaseIBA
06/2020 - 01/2019
2AcidsIBA
01/2020 - 01/2018
2Parathion (Ethyl Parathion)IBA
01/2016 - 10/2015
2FibrinIBA
11/2015 - 12/2012
2LipocalinsIBA
08/2014 - 10/2007
2Protein CIBA
08/2014 - 09/2012
2Pharmaceutical PreparationsIBA
05/2013 - 02/2012
2Toll-Like Receptor 4IBA
02/2013 - 12/2007
2Biomarkers (Surrogate Marker)IBA
02/2011 - 11/2009
2Peroxynitrous Acid (Peroxynitrite)IBA
03/2008 - 08/2004
1Fibrinogen (Factor I)FDA Link
10/2021
1Blood Proteins (Serum Proteins)IBA
10/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2021
1indium-bleomycinIBA
01/2021
1Histones (Histone)IBA
01/2021
1Oxidants (Oxidizing Agents)IBA
11/2020
1PhosgeneIBA
11/2020
1RicinIBA
11/2020
1Chemical Warfare AgentsIBA
11/2020
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
06/2020
1Air Pollutants (Pollutants, Air)IBA
01/2020
1EndotoxinsIBA
01/2020
1SmokeIBA
01/2020
1LipidsIBA
12/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2018
1PentosesIBA
01/2017
1XyluloseIBA
01/2017
12,3-pentanedioneIBA
01/2017
1QuinonesIBA
01/2017
1Diacetyl (Biacetyl)IBA
01/2017
1Complement System Proteins (Complement)IBA
08/2016

Therapy/Procedure

9Therapeutics
11/2020 - 11/2009
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
10/2020
1Immunotherapy
08/2016